Strong alignment between Gov’t Life Sciences Vision & Discovery Park strategy

Strong alignment between Gov’t Life Sciences Vision & Discovery Park strategy

Areas of focus include innovation, manufacturing, skills & dementia

Sandwich, Kent, July 12 2021 – There is strong complementarity between the UK Government’s new Life Sciences Vision1 and the strategy at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies. The Government’s 10-year plan covers accelerating the delivery of innovations to patients, solving healthcare issues such as dementia, onshoring manufacturing and the creation of highly skilled jobs. Digital tools and ‘Levelling Up’ health and wealth across the UK are also highlighted. With its Strategic Pillars of Innovation, STEM skills, Digital & AI and Manufacturing, Discovery Park will collaborate with the Government to make the UK the leading location worldwide for life sciences.

The Life Sciences Vision is part of the UK Government’s Build Back Better post-pandemic growth plan. Life Sciences Opportunity Zones such as Discovery Park are expected to play an important part in this growth.

Lessons learned during the pandemic include the importance of a strong domestic manufacturing base and supply chain. With its manufacturing facilities and space for expansion, Discovery Park’s vision of a Manufacturing Village is strongly aligned with the Government’s plan for Manufacturing Clusters.

The Park’s Innovation activities include delivery in 2022 of a new Incubator facility for 20-25 SMEs, while further developments its Skills strategy will be announced in due course. As a central nervous system disorder, dementia (named one of seven great healthcare challenges by the Government) is of interest to Discovery Park and tenants such as neuroscience CRO Transpharmation.

Mayer Schreiber, CEO of Discovery Park, said, ‘The Government’s new Life Sciences Vision is an exciting strategy for the sector in the UK and we are delighted to see so many areas of mutual focus. Companies at Discovery Park played an important role in the pandemic response - we expect them to continue to contribute to growth of the UK life sciences sector which employs more than 250,000 people with an annual turnover of £80bn2.’



For more information about Discovery Park please contact:
Discovery Park
Emma Palmer Foster, Communications
+44 (0)7880 787185

Editor’s Notes
Discovery Park is a thriving part of the South East’s life science community. The site offers high quality laboratory, office and manufacturing facilities, the space and support to expand, access to local finance, and a strong local scientific talent pool. It was named recently one of six prestigious UK Life Sciences Opportunity Zones by the UK Government, and is developing its vision for a Manufacturing Village.
The growing tenant community includes Pfizer, which built the site’s reputation as a centre for drug discovery and discovered some of the most famous drugs in the world here. Other tenants include Algaecytes, Canterbury Christ Church University, Concept Life Sciences, eXroid, Firza, Genea Biomedx, LGC, Viatris, Psyros Diagnostics, Salvensis, VisusNano and Wren Healthcare. Discovery Park is home to 160+ companies employing 3,500 employees in total. With easy connections to London, Europe and the world Discovery Park is a great place to build and grow your biotech, medtech or pharma business. Discover more via our website: email: or call: 01304 614060.

More within